The relatively low-cost technology has saved millions of lives—and dollars.
Myocarditis following mRNA COVID-19 vaccination is real but is no longer an issue. The virus itself was causing myocarditis at comparable or higher rates.
The White House Office of Management and Budget has been slow to authorize the release of funds to the NIH.
Means defended removing the newborn dose of the hepatitis B vaccine from the childhood immunization schedule.
Rates climbed from 68% in January 2017 to a peak of 84% in February 2023 before dropping to 73% by August 2025.
The latest FDA reversal is welcome, but the episode of first denying Moderna review of its mRNA flu vaccine deserves close examination.
Between federal lawsuits, sweeping schedule changes, and states mobilizing their own legal challenges, the last few weeks have been a whirlwind. Let's dive right in.
Experts say the move will hobble the United States’ ability to respond to future infectious disease threats.
The vaccine has reduced cervical cancer by nearly 90% in women vaccinated as teens and has been studied in more than 50 randomized controlled trials.
Pressuring Gavi, the Vaccine Alliance to phase out vaccines containing thimerosal is not evidence-based; it's ideological—and part of a pattern.
